Appearance of HbeAg in an occult persistent hepatitis B virus infection

Intervirology

Volumn 53, Issue 3, 2010, Pages 173-175

  Paparella, Concetta ^a   De Rosa, Filomena ^a   Longo, Roberta ^b   Cappiello, Giuseppina ^b   Ursitti, Antonella ^b   Rosa, Marisa ^a   Morosetti, Massimo ^a   Spanò, Alberto ^b  

^a Ospedale 'GB Grassi'   (Italy)

^b SANDRO PERTINI HOSPITAL   (Italy)

Author keywords

DNA sequencing; HBsAg assays; HBsAg mutants; Hepatitis B virus; Occult hepatitis

Indexed keywords

ANASTROZOLE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

AGED; ARTICLE; CASE REPORT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SYSTEMIC DISEASE; VIREMIA; VIRUS MUTATION; VIRUS REPLICATION;

AGED; DNA, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 75549088616     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000279765     Document Type: Article

References (9)

1. Yeo W, Chan TC, Leung NWY, Lam WY, Mo FKF, Chu MT, Chan HLY, Hui EP, Lei KIK, Mok TSK, Chan PKS: Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009; 27: 605-611.
2. Raimondo G, Allain J-P, Brunetto MR, Buendia M-A, Chen D-S, Colombo M, Craxì A, Donato F, Ferrari C, Gaeta GB, Gerlich WH, Levrero M, Locarnini S, Michalak T, Mondelli MU, Pawlotsky J-M, Pollicino T, Prati D, Puoti M, Samuel D, Shouval D, Smedile A, Squadrito G, Trépo C, Villa E, Will A, Zanetti AR, Zoulim F: Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-657.
3. Song EY, Yun YM, Park MH, Seo DH: Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology 2009; 52: 57-62.
4. Gerlich WH: Diagnostic problems caused by HBsAg mutants: a consensus report of an expert meeting. Intervirology 2004; 47: 310-313.
5. Werle B, Cinquin K, Marcellin P, Pol S, Maynard M, Trépo C, Zoulim F: Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy. J Viral Hepat 2004; 11: 74-83. (Pubitemid 38221621)
6. Kuhns MC, McNamara AL, Holzmayer V, Lou SC, Busch MP: Frequency of diagnostically significant hepatitis B surface antigens mutants. J Med Virol 2007; 79(suppl 1):S42-S46. (Pubitemid 47479873)
7. Scheiblauer H, Soboll H, Nick S: Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection. J Med Virol 2006; 78:S66-S70. (Pubitemid 43993469)
8. Manzini P, Abate ML, Valpreda C, Milanesi P, Curti F, Rizzetto M, Smedile A: Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor. Transfusion 2009; 49: 757-764.
9. Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A: Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol 2009; 81: 815-825.